AT2 receptors: Functional relevance in cardiovascular disease
Open accessThe DOI matches its Crossref record; 401 of the 401 references it cites were found in a registry or an index.
Abstract
The renin angiotensin system (RAS) is intricately involved in normal cardiovascular homeostasis. Excessive stimulation by the octapeptide angiotensin II contributes to a range of cardiovascular pathologies and diseases via angiotensin type 1 receptor (AT1R) activation. On the other hand, tElsevier Inc.he angiotensin type 2 receptor (AT2R) is thought to counter-regulate AT1R function. In this review, we describe the enhanced expression and function of AT2R in various cardiovascular disease settings. In addition, we illustrate that the RAS consists of a family of angiotensin peptides that exert cardiovascular effects that are often distinct from those of Ang II. During cardiovascular disease, there is likely to be an increased functional importance of AT2R, stimulated by Ang II, or even shorter angiotensin peptide fragments, to limit AT1R-mediated overactivity and cardiovascular pathologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493 · cited 2×
“Activation of local RAS seems to be involved in the progression of kidney damage, with results of large clinical trials confirming the beneficial effects of ACE inhibitors and AT 1 R antagonists (Brenner et al., 2001; Lewis et al., 2001; Parving et al., 2001) , however as yet the role of the AT 2 R in the pathogenesis…”
ResultLewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987 · cited 2×
“Activation of local RAS seems to be involved in the progression of kidney damage, with results of large clinical trials confirming the beneficial effects of ACE inhibitors and AT 1 R antagonists (Brenner et al., 2001; Lewis et al., 2001; Parving et al., 2001) , however as yet the role of the AT 2 R in the pathogenesis…”
ResultAngiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923 · cited 1×
“Moreover, ACE2 acts as a receptor for the severe-acute respiratory syndrome (SARS) coronavirus (Li et al., 2003) where it may serve a protective role (Hamming et al., 2007).”
BackgroundLevy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699 · cited 4×
“Clearly, neither animal nor human studies to date have been able to delineate a consistent influence of AT 2 R stimulation on LVH. Current equivocal results may be partly explained by the range of animal models, indices measured, drugs, doses and treatment times employed by investigators, but most likely reflect the c…”
BackgroundInfluentialDahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839 · cited 2×
“These findings also have further implications in terms of the progression of atherosclerosis, as decreased oxidative stress (typically superoxide anion production) increases the bioavailability of the potent anti-atherosclerotic vasodilator NO (Cai & Harrison, 2000).”
Telmisartan, ramipril, or both in patients at high risk for vascular events
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801317 · Cited by 3,502
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873 · cited 2×
“Activation of local RAS seems to be involved in the progression of kidney damage, with results of large clinical trials confirming the beneficial effects of ACE inhibitors and AT 1 R antagonists (Brenner et al., 2001; Lewis et al., 2001; Parving et al., 2001) , however as yet the role of the AT 2 R in the pathogenesis…”
ResultAngiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735
Julius, S., Kjeldsen, S. E., Weber, M., Brunner, H. R., Ekman, S., Hansson, L., Hua, T., Laragh, J., McInnes, G. T., Mitchell, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16451-9 · Cited by 2,558
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,535
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485 · cited 4×
“In contrast to the wide distribution of ACE, ACE2 expression was initially thought to be restricted to endothelial and VSMCs of the heart and kidney (Donoghue et al., 2000; Tipnis et al., 2000; Crackower et al., 2002) although a more widespread distribution is emerging (see Hamming et al., 2007).”
BackgroundInfluentialInternational Union of Pharmacology. XXIII. The Angiotensin II Receptors
de Gasparo, M., Catt, K. J., Inagami, T., Wright, J. W., & Unger, T. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01458-3 · Cited by 2,132 · cited 8×
“Ang II is susceptible to degradation by aminopeptidases, resulting in fragments such as Ang III and Ang IV, which may in themselves possess biological activity (Ferrario & Iyer, 1998; de Gasparo et al., 2000) .”
BackgroundInfluentialA Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,009 · cited 4×
“In contrast to the wide distribution of ACE, ACE2 expression was initially thought to be restricted to endothelial and VSMCs of the heart and kidney (Donoghue et al., 2000; Tipnis et al., 2000; Crackower et al., 2002) although a more widespread distribution is emerging (see Hamming et al., 2007).”
BackgroundInfluentialAngiotensin II receptors and angiotensin II receptor antagonists.
Timmermans, P. B., Wong, P. C., Chiu, A. T., Herblin, W. F., Benfield, P., Carini, D. J., Lee, R. J., Wexler, R. R., Saye, J. A., & Smith, R. D. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00446-6 · Cited by 1,853 · cited 2×
“On the other hand, the tetrahydroimidazopyridine compounds, PD123177 and PD123319, have been shown to be 3500-fold more selective for the AT2R than the AT1R (Timmermans et al., 1991; Timmermans et al., 1993), while CGP42112 exhibits over 1000-fold selectivity for AT2R (Whitebread et al., 1989).”
BackgroundAngiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
Santos, R. A. S., e Silva, A. C. S., Maric, C., Silva, D. M. R., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V. B., Lopes, M. T., Bader, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432869100 · Cited by 1,801 · cited 5×
“, 1998), and a low affinity for AT1R (Rowe et al., 1995; Santos et al., 2003) and yet many of its reported physiological effects”
BackgroundInfluentialPhysiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · cited 2×
“…it is now well accepted that in addition to systemic effects, local synthesis of Ang II exerts bothautocrine andparacrine functions, influencing cellular growth andregionalhaemodynamics ina tissue-specificmanner (Johnston,1992; Zimmerman & Dunham, 1997; de Gasparo et al., 2000; Paul et al., 2006).”
BackgroundAngiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733 · cited 26×
“Vascular remodelling associated with hypertension occurs at all levels of the vascular tree, and increased local expression of RAS components and subsequent enhanced local Ang II production (Shiota et al., 1992; Jandeleit-Dahm et al., 1997; Wang et al., 2003), implies an important role of the RAS in this process.”
BackgroundInfluentialFerrario, C. M., Jessup, J., Chappell, M. C., Averill, D. B., Brosnihan, K. B., Tallant, E. A., Diz, D. I., & Gallagher, P. E. (2005) · Circulation · doi:10.1161/circulationaha.104.510461 · Cited by 1,565 · cited 9×
“Other studies have suggested that the MasR can heterodimerise with AT1R to inhibit the effects of Ang II (Kostenis et al., 2005).”
BackgroundInfluentialMolecular Mechanisms of Myocardial Remodeling
SWYNGHEDAUW, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.215 · Cited by 1,460 · cited 2×
“When the relative proportions of cell types within the heart remain unchanged, hypertrophy is termed adaptive or physiological, however, by far the most prevalent form of cardiac hypertrophy involves disproportionate changes within the cardiac tissue, which ultimately decrease cardiac function, and results in LVH and…”
BackgroundHydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J., Godbout, K., Parsons, T., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,407 · cited 2×
“ACE2 is a recently discovered homologue of ACE, with 56% similar homology with the N-terminal domain of ACE (Donoghue et al., 2000; Tipnis et al., 2000; Vickers et al., 2002).”
BackgroundAngiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E–deficient mice
Daugherty, A., Manning, M. W., & Cassis, L. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7818 · Cited by 1,368 · cited 2×
“Ang II is recognized as a potent mediator in the pathogenesis of atherosclerosis (Daugherty et al., 2000) , with AT 1 -receptor activation by Ang II promoting vascular inflammation, cellular proliferation and oxidative stress which are considered key stages in the initiation and progression of the disease (Dzau, 2001;…”
BackgroundNguyen, G., Delarue, F., Burcklé, C., Bouzhir-Sima, L., Giller, T., & Sraer, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14276 · Cited by 1,276 · cited 6×
“A specific renin/prorenin receptor (P)RR was first identified in cultured human mesangial cells (Nguyen et al., 2002), and has since been found to be expressed at relatively high levels in rat and human”
BackgroundInfluentialLakatta, E. G., & Levy, D. (2003) · Circulation · doi:10.1161/01.cir.0000048893.62841.f7 · Cited by 1,268 · cited 1×
“These cardiovascular adaptations are seen in both elderly normotensive and hypertensive subjects (Lakatta & Levy, 2003) , indicating that modifications are more than a mere consequence of confounding cardiovascular complications such as arterial hypertension, decreased aortic compliance and atherosclerosis, which are…”
BackgroundNguyen, G., Delarue, F., Burcklé, C., Bouzhir, L., Giller, T., & Sraer, J.-D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214276 · Cited by 1,137
Senni, M., Tribouilloy, C. M., Rodeheffer, R. J., Jacobsen, S. J., Evans, J. M., Bailey, K. R., & Redfield, M. M. (1998) · Circulation · doi:10.1161/01.cir.98.21.2282 · Cited by 1,088 · cited 1×
“Given the correlation between LVH and the poor long-term prognosis of patients exhibiting such modification of cardiac structure (Levy et al., 1990; Rihal et al., 1994; Senni et al., 1998), this area of AT2R function undoubtedly requires further research.”
BackgroundStoll, M., Steckelings, U. M., Paul, M., Bottari, S. P., Metzger, R., & Unger, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117710 · Cited by 906 · cited 2×
“Several signaling pathways involve activation of protein phosphatases, whose function is to dephosphorylate and thus inactivate MAP kinases such as ERK-1 and ERK-2, resulting in inhibition of both AT 1 Rand other 'classical' growth factor-mediated pathways involved in cellular growth and differentiation (Stoll et al.,…”
BackgroundEffects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor
Ichiki, T., Labosky, P. A., Shiota, C., Okuyama, S., Imagawa, Y., Fogo, A., Niimura, F., Ichikawa, I., Hogan, B. L. M., & lnagami, T. (1995) · Nature · doi:10.1038/377748a0 · Cited by 858 · cited 2×
“In AT 2 R knockout mice (Hein et al., 1995; Ichiki et al., 1995; Gross et al., 2000a) , and rats administered AT 2 R antisense to 'knockdown' receptor expression (Wang et al., 2004) , both an increase in basal BP and/ or potentiation of the pressor response to exogenous Ang II have been attributed to the absence of AT…”
BackgroundPreliminary biochemical characterization of two angiotensin II receptor subtypes
Whitebread, S., Mele, M., Kamber, B., & de Gasparo, M. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92133-5 · Cited by 777 · cited 3×
“The Ang II derived peptide CGP42112 has long been the gold standard for determining functional and selective AT2R activity (Whitebread et al., 1989; de Gasparo et al., 2000).”
BackgroundSchrader, J., Lüders, S., Kulschewski, A., Hammersen, F., Plate, K., Berger, J., Zidek, W., Dominiak, P., Diener, H. C., & the MOSES Study Group (2005) · Stroke · doi:10.1161/01.str.0000166048.35740.a9 · Cited by 766 · cited 2×
“On the basis of several large-scale clinical trials, it is now accepted that chronic inhibition of the RAS can provide neuroprotection, with reduced occurrence of stroke in high-risk populations (Dahlof et al., 2002; Arnold et al., 2003; Chapman et al., 2004; Schrader et al., 2005) .”
BackgroundTissue Angiotensin and Pathobiology of Vascular Disease: A Unifying Hypothesis
Dzau, V. J. (2001) · Hypertension · doi:10.1161/01.hyp.37.4.1047 · Cited by 750 · cited 4×
“Ang II is recognized as a potent mediator in the pathogenesis of atherosclerosis (Daugherty et al., 2000) , with AT 1 -receptor activation by Ang II promoting vascular inflammation, cellular proliferation and oxidative stress which are considered key stages in the initiation and progression of the disease (Dzau, 2001;…”
BackgroundInfluentialBehavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice
Hein, L., Barsh, G. S., Pratt, R. E., Dzau, V. J., & Kobilka, B. K. (1995) · Nature · doi:10.1038/377744a0 · Cited by 742 · cited 2×
“In AT 2 R knockout mice (Hein et al., 1995; Ichiki et al., 1995; Gross et al., 2000a) , and rats administered AT 2 R antisense to 'knockdown' receptor expression (Wang et al., 2004) , both an increase in basal BP and/ or potentiation of the pressor response to exogenous Ang II have been attributed to the absence of AT…”
BackgroundLambert, D. W., Yarski, M., Warner, F. J., Thornhill, P., Parkin, E. T., Smith, A. I., Hooper, N. M., & Turner, A. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505111200 · Cited by 694 · cited 2×
“In addition, ACE2 is known to undergo proteolytic shedding of its extracellular ectodomain to release a soluble form of ACE2 in plasma that maintains catalytic activity (Lambert et al., 2005; Warner et al., 2005).”
BackgroundBrilla, C. G., Zhou, G., Matsubara, L., & Weber, K. T. (1994) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1994.1098 · Cited by 694 · cited 4×
“In rat cardiac fibroblasts, collagen production was reduced by inhibition of either AT1 or AT2R (Brilla et al., 1994; Brilla et al., 1995), and chronic blockade of both AT1R and AT2R with Sar1Ile8Ang II in rats also decreased collagen deposition, suggesting a stimulatory role of AT2R in collagen…”
BackgroundInfluentialNakajima, M., Hutchinson, H. G., Fujinaga, M., Hayashida, W., Morishita, R., Zhang, L., Horiuchi, M., Pratt, R. E., & Dzau, V. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10663 · Cited by 680 · cited 1×
“Nakajima et al. (1995) first reported AT2R involvement in neointimal formation in rats by transfecting an AT2R expression vector into the balloon-injured rat carotid artery and observed that over-expression of AT2R attenuated neointimal formation.”
BackgroundWarnholtz, A., Nickenig, G., Schulz, E., Macharzina, R., Bräsen, J. H., Skatchkov, M., Heitzer, T., Stasch, J. P., Griendling, K. K., Harrison, D. G., et al. (1999) · Circulation · doi:10.1161/01.cir.99.15.2027 · Cited by 676 · cited 1×
“…of studies using transgenic animal models and human tissues, that demonstrate an increase in AT1-receptor density in hypercholesterolemia (Nickenig & Bohm, 1997; Warnholtz et al., 1999), as well as increased expression of ACE in atherosclerotic lesions (Diet et al., 1996; Fukuhara et al., 2000).”
BackgroundThe ACCESS Study: Evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors
Schrader, J., Lüders, S., Kulschewski, A., Berger, J., Zidek, W., Treib, J., Einhäupl, K., Diener, H. C., & Dominiak, P. (2003) · Stroke · doi:10.1161/01.str.0000075777.18006.89 · Cited by 652 · cited 2×
“Neuroprotection has also been demonstrated by candesartan cilexetil in an acute setting (Schrader et al., 2003) .”
BackgroundRICE, G. I., THOMAS, D. A., GRANT, P. J., TURNER, A. J., & HOOPER, N. M. (2004) · Biochemical Journal · doi:10.1042/bj20040634 · Cited by 619 · cited 2×
“More importantly, ACE2 may also directly metabolise Ang II to form Ang (1–7), and this reaction occurs at a faster rate than the formation of Ang (1–9) from Ang I (Carey & Siragy, 2003; Rice et al., 2004).”
BackgroundLiu, Y. H., Yang, X. P., Sharov, V. G., Nass, O., Sabbah, H. N., Peterson, E., & Carretero, O. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119360 · Cited by 603 · cited 10×
“…pathways has also been demonstrated following AT2R stimulation in vivo, in the vasculature of rats (Siragy & Carey, 1996, 1997, 1999; Siragy et al., 2000, 2001; Walters et al., 2005), and mice (Tsutsumi et al., 1999), and in cardiac growth responses (Liu et al., 1997; Bartunek et al., 1999).”
BackgroundInfluentialCarey, R. M., & Siragy, H. M. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0001 · Cited by 603 · cited 1×
“More importantly, ACE2 may also directly metabolise Ang II to form Ang (1–7), and this reaction occurs at a faster rate than the formation of Ang (1–9) from Ang I (Carey & Siragy, 2003; Rice et al., 2004).”
BackgroundIshiyama, Y., Gallagher, P. E., Averill, D. B., Tallant, E. A., Brosnihan, K. B., & Ferrario, C. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000124667.34652.1a · Cited by 564 · cited 2×
“Furthermore, Ishiyama et al. (2004) have reported that ACE2 mRNA expression was increased by AT1R inhibition following myocardial infarction (MI), and spironolactone treatment also increased ACE2 in heart failure patients (Keidar et al., 2005).”
BackgroundTsutsumi, Y., Matsubara, H., Masaki, H., Kurihara, H., Murasawa, S., Takai, S., Miyazaki, M., Nozawa, Y., Ozono, R., Nakagawa, K., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7886 · Cited by 561 · cited 2×
“In mice with targeted over-expression of vascular (Tsutsumi et al., 1999) or cardiac (Masaki et al., 1998) AT2R, there was no change in basal BP, although acute Ang II infusion decreased BP. Stimulation of AT2R by chronic Ang II infusion during AT1R blockade failed to decrease BP (Cao et al., 1999;…”
BackgroundExtracellular Matrix Remodeling in Heart Failure: A Role for De Novo Angiotensin II Generation
Weber, K. T. (1997) · Circulation · doi:10.1161/01.cir.96.11.4065 · Cited by 557 · cited 2×
“correlated with the occurrence of future cardiovascular disorders such as left ventricular hypertrophy (LVH), cardiac failure, arteriosclerosis, and stroke (Unger et al., 1996; Weber, 1997; Simon et al., 1998).”
BackgroundNonpeptide angiotensin II receptor antagonists
Timmermans, P. B. M. W. M., Wong, P. C., Chiu, A. T., & Herblin, W. F. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90498-h · Cited by 549
Cardiac Actions of Angiotensin II: Role of an Intracardiac Renin-Angiotensin System
Baker, K. M., Booz, G. W., & Dostal, D. E. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.001303 · Cited by 517 · cited 2×
“IRAP has been localised in tissues such as heart, lung, kidney, and brain, and ligand binding results in effects such as enhancement of cognitive function (Wright et al., 1993; Wright et al., 1999) modulation of blood flow (Swanson et al., 1992; Coleman et al., 1998) , increased natriuresis (Ardaillou & Chansel, 1997)…”
BackgroundCounterregulatory Actions of Angiotensin-(1-7)
Ferrario, C. M., Chappell, M. C., Tallant, E. A., Brosnihan, K. B., & Diz, D. I. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.535 · Cited by 509 · cited 2×
“Alternatively (but to amuch lesser degree), Ang I may be directly converted to Ang (1–7) by tissue endopeptidases (Ferrario et al.,1997).”
BackgroundAT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration
AbdAlla, S., Lother, H., & Quitterer, U. (2000) · Nature · doi:10.1038/35024095 · Cited by 503 · cited 2×
“Like AT 1 R which are reported to form heterodimers (AbdAlla et al., 2000 (AbdAlla et al., , 2001b , both hetero-and homo-oligomers of AT 2 Rs have been reported.”
BackgroundIncreased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness
AbdAlla, S., Lother, H., el Massiery, A., & Quitterer, U. (2001) · Nature Medicine · doi:10.1038/nm0901-1003 · Cited by 496 · cited 3×
“…and fetal fibroblasts, and subsequent stimulation of cells with Ang II resulted in decreased expression of the of AT1R-associated G-proteins, Gαi/o and Gαq/11, suggesting that such an interaction between receptor subtypes may contribute to AT2R-mediated antagonism of AT1R (AbdAlla et al., 2001a).”
BackgroundSiragy, H. M., & Carey, R. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119531 · Cited by 485 · cited 4×
“One of the most frequently reported signaling pathways for AT2R stimulation in vasculature has been increased production of cyclic guanine 3′,5′-monophosphate (cGMP), nitric oxide (NO) and bradykinin (BK), as was first described by Siragy and Carey (1996, 1997): see Widdop et al. (2003) for review.”
BackgroundInfluentialThe Angiotensin II AT2 Receptor Is an AT1Receptor Antagonist
AbdAlla, S., Lother, H., Abdel-tawab, A. M., & Quitterer, U. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105253200 · Cited by 463 · cited 3×
“…and fetal fibroblasts, and subsequent stimulation of cells with Ang II resulted in decreased expression of the of AT1R-associated G-proteins, Gαi/o and Gαq/11, suggesting that such an interaction between receptor subtypes may contribute to AT2R-mediated antagonism of AT1R (AbdAlla et al., 2001a).”
BackgroundEvidence That the Angiotensin IV (AT4) Receptor Is the Enzyme Insulin-regulated Aminopeptidase
Albiston, A. L., McDowall, S. G., Matsacos, D., Sim, P., Clune, E., Mustafa, T., Lee, J., Mendelsohn, F. A. O., Simpson, R. J., Connolly, L. M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100512200 · Cited by 461 · cited 9×
“Following identification of the AT4R as an aminopeptidase (Albiston et al., 2001), it has been proposed that AT4R ligands act by inhibiting IRAP catalytic activity, thereby reducing IRAP cleavage of substrates such as lys-bradykinin and vasopressin and prolonging their biological activity (Lew et…”
BackgroundMethodInfluentialAngiotensin AT1/AT2 Receptors: Regulation, Signalling and Function
KASCHINA, E., & UNGER, T. (2003) · Blood Pressure · doi:10.1080/08037050310001057 · Cited by 458 · cited 2×
“The topic of AT2R signalling has recently been extensively reviewed (Hannan & Widdop, 2004; Kaschina & Unger, 2003; Steckelings et al., 2005), and so will only be mentioned briefly.”
BackgroundIchihara, A., Hayashi, M., Kaneshiro, Y., Suzuki, F., Nakagawa, T., Tada, Y., Koura, Y., Nishiyama, A., Okada, H., Uddin, M. N., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421398 · Cited by 456
Rihal, C. S., Nishimura, R. A., Hatle, L. K., Bailey, K. R., & Tajik, A. J. (1994) · Circulation · doi:10.1161/01.cir.90.6.2772 · Cited by 438 · cited 2×
“Clearly, neither animal nor human studies to date have been able to delineate a consistent influence of AT 2 R stimulation on LVH. Current equivocal results may be partly explained by the range of animal models, indices measured, drugs, doses and treatment times employed by investigators, but most likely reflect the c…”
BackgroundRegulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction.
Nio, Y., Matsubara, H., Murasawa, S., Kanasaki, M., & Inada, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117675 · Cited by 435 · cited 2×
“In animal models, AT2R expression is also increased by cardiac hypertrophy and heart failure, either in terms of absolute numbers, or relative to AT1R expression (Suzuki et al., 1993; Lopez et al., 1994; Nio et al., 1995; Ohkubo et al., 1997; Bartunek et al., 1999; Busche et al., 2000).”
BackgroundThe emerging role of ACE2 in physiology and disease
Hamming, I., Cooper, M., Haagmans, B., Hooper, N., Korstanje, R., Osterhaus, A., Timens, W., Turner, A., Navis, G., & van Goor, H. (2007) · The Journal of Pathology · doi:10.1002/path.2162 · Cited by 434 · cited 7×
“, 2003) where it may serve a protective role (Hamming et al., 2007).”
BackgroundInfluentialIncreased Accumulation of Tissue ACE in Human Atherosclerotic Coronary Artery Disease
Diet, F., Pratt, R. E., Berry, G. J., Momose, N., Gibbons, G. H., & Dzau, V. J. (1996) · Circulation · doi:10.1161/01.cir.94.11.2756 · Cited by 426 · cited 2×
“The role of Ang II in atherosclerosis is evident in a number of studies using transgenic animal models and human tissues, that demonstrate an increase in AT 1 -receptor density in hypercholesterolemia (Nickenig & Bohm, 1997; Warnholtz et al., 1999) , as well as increased expression of ACE in atherosclerotic lesions (D…”
BackgroundMyocardial infarction increases ACE2 expression in rat and humans
Burrell, L. M., Risvanis, J., Kubota, E., Dean, R. G., MacDonald, P. S., Lu, S., Tikellis, C., Grant, S. L., Lew, R. A., Smith, A. I., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi114 · Cited by 423 · cited 2×
“Early investigations regarding ACE2 suggested that ACE2 mRNA was increased in both human and animal models of heart failure (Goulter et al., 2004; Burrell et al., 2005) and decreased in genetically hypertensive rats (Crackower et al., 2002), sparking interest that ACE2 may play an important…”
BackgroundHuang, Y., Wongamorntham, S., Kasting, J., McQuillan, D., Owens, R. T., Yu, L., Noble, N. A., & Border, W. (2006) · Kidney International · doi:10.1038/sj.ki.5000011 · Cited by 423 · cited 3×
“Huang et al. (2006), demonstrated that treatment of cultured mesangial cells with human and rat recombinant renin increased levels of the pro-fibrotic cytokine transforming growth factor, TGF-β1, and that this effect was not influenced by an inhibitor of the enzymatic activity of renin (RO…”
BackgroundInfluentialG-Protein–Coupled Receptor Mas Is a Physiological Antagonist of the Angiotensin II Type 1 Receptor
Kostenis, E., Milligan, G., Christopoulos, A., Sanchez-Ferrer, C. F., Heringer-Walther, S., Sexton, P. M., Gembardt, F., Kellett, E., Martini, L., Vanderheyden, P., et al. (2005) · Circulation · doi:10.1161/01.cir.0000160867.23556.7d · Cited by 415 · cited 2×
“Other studies have suggested that the MasR can heterodimerise with AT1R to inhibit the effects of Ang II (Kostenis et al., 2005).”
BackgroundSpironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress
Virdis, A., Neves, M. F., Amiri, F., Viel, E., Touyz, R. M., & Schiffrin, E. L. (2002) · Hypertension · doi:10.1161/01.hyp.0000034738.79310.06 · Cited by 399 · cited 4×
“Furthermore, other factors involved in cellular growth and ECM production which are known to be stimulated by Ang II, such as growth factors (Parker et al., 1998; Su et al., 2002) , factors involved in the inflammatory response (Chou et al., 1998) and reactive oxygen species (ROS) (Virdis et al., 2002; Keidar et al.,…”
BackgroundInfluentialAT2Receptor Stimulation Increases Aortic Cyclic GMP in SHRSP by a Kinin-Dependent Mechanism
Gohlke, P., Pees, C., & Unger, T. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.349 · Cited by 395 · cited 3×
“However, similar studies performed in SHR were unable to demonstrate corresponding Ang II-mediated vasodilatation during AT1R blockade (Gohlke et al., 1998).”
BackgroundResultFerrario, C. M., Trask, A. J., & Jessup, J. A. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00618.2005 · Cited by 385 · cited 9×
“Other studies have suggested that the MasR can heterodimerise with AT1R to inhibit the effects of Ang II (Kostenis et al., 2005).”
BackgroundInfluentialSantos, R. A. S., Campagnole-Santos, M. J., & Andrade, S. P. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00138-5 · Cited by 380 · cited 5×
“A number of cardiovascular effects have been attributed to Ang (1–7) (Santos et al., 2000) acting via MasR (Ferrario et al., 2005b; Santos & Ferreira, 2007) although there is evidence that Ang (1–7) can act independently of Ang (1–7)/MasR (Walters et al., 2005).”
BackgroundInfluentialSubclasses of angiotensin II binding sites and their functional significance.
Dudley, D. T., Panek, R. L., Major, T. C., Lu, G. H., Bruns, R. F., Klinkefus, B. A., Hodges, J. C., & Weishaar, R. E. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09488-x · Cited by 374 · cited 2×
“On the other hand, there are substantial binding data suggesting that Ang III has 5–10 times higher affinity for AT2R over AT1R (Dudley et al., 1990; Timmermans et al., 1991; Rosenstrom et al., 2004), and indeed possesses higher affinity than Ang II itself at AT2R (Mukoyama et al., 1995; Bouley et…”
BackgroundNishimura, H., Yerkes, E., Hohenfellner, K., Miyazaki, Y., Ma, J., Hunley, T. E., Yoshida, H., Ichiki, T., Threadgill, D., Phillips, J. A., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80169-0 · Cited by 363 · cited 2×
“However, the interpretation of these findings is somewhat unclear as the same group has reported that the G allele represents either decreased AT2R function (Nishimura et al., 1999; Alfakih et al., 2004; Alfakih et al., 2005) or increased AT2R function (Warnecke et al., 2005; Strauss & Hall, 2006).”
BackgroundAngiotensin II stimulation of protein synthesis and cell growth in chick heart cells
Baker, K. M., & Aceto, J. F. (1990) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1990.259.2.h610 · Cited by 353 · cited 2×
“IRAP has been localised in tissues such as heart, lung, kidney, and brain, and ligand binding results in effects such as enhancement of cognitive function (Wright et al., 1993; Wright et al., 1999) modulation of blood flow (Swanson et al., 1992; Coleman et al., 1998) , increased natriuresis (Ardaillou & Chansel, 1997)…”
BackgroundAlterations of Nitric Oxide Synthase Expression With Aging and Hypertension in Rats
Chou, T.-C., Yen, M.-H., Li, C.-Y., & Ding, Y.-A. (1998) · Hypertension · doi:10.1161/01.hyp.31.2.643 · Cited by 339 · cited 2×
“Furthermore, other factors involved in cellular growth and ECM production which are known to be stimulated by Ang II, such as growth factors (Parker et al., 1998; Su et al., 2002) , factors involved in the inflammatory response (Chou et al., 1998) and reactive oxygen species (ROS) (Virdis et al., 2002; Keidar et al.,…”
BackgroundACE and ACE2 Activity in Diabetic Mice
Wysocki, J., Ye, M., Soler, M. J., Gurley, S. B., Xiao, H. D., Bernstein, K. E., Coffman, T. M., Chen, S., & Batlle, D. (2006) · Diabetes · doi:10.2337/db06-0033 · Cited by 339 · cited 1×
“Such inconsistency in results regarding ACE2 expression and activity may be at least partially due to the methods employed, as only poor correlation between ACE2 mRNA and both protein expression and activity has recently been reported in diabetic mice (Wysocki et al., 2006).”
MethodAltered blood pressure responses and normal cardiac phenotype in ACE2-null mice
Gurley, S. B., Allred, A., Le, T. H., Griffiths, R., Mao, L., Philip, N., Haystead, T. A., Donoghue, M., Breitbart, R. E., Acton, S. L., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci16980 · Cited by 334 · cited 2×
“…have increased plasma and tissue levels of Ang II, due to both decreasedmetabolism of plasma Ang II, and increased tissue synthesis as a result of elevated Ang I, suggesting an important function of ACE2 to regulate Ang II levels (Crackower et al., 2002; Gurley et al., 2006; Yamamoto et al., 2006).”
BackgroundPrevention of angiotensin II-induced cardiac remodeling by angiotensin-(1–7)
Grobe, J. L., Mecca, A. P., Lingis, M., Shenoy, V., Bolton, T. A., Machado, J. M., Speth, R. C., Raizada, M. K., & Katovich, M. J. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00937.2006 · Cited by 332
Design, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT2 Receptor Agonist
Wan, Y., Wallinder, C., Plouffe, B., Beaudry, H., Mahalingam, A. K., Wu, X., Johansson, B., Holm, M., Botoros, M., Karlén, A., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049715t · Cited by 330 · cited 26×
“However, in analogous experiments, Duke et al. (2005a) reported that AT2R contributed to the BP-lowering and mesenteric vasodilator effect of candesartan in normotensive, but not hypertensive (SHR, 2K1C) rats.”
BackgroundInfluentialSiragy, H. M., Inagami, T., Ichiki, T., & Carey, R. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6506 · Cited by 328 · cited 1×
“Moreover, PD123319 reversed the natriuretic and diuretic effects of candesartan, suggesting an involvement of AT2R in the effect of the latter compound (Hakam & Hussain, 2005), consistent with earlier studies (Siragy & Carey, 1999; Siragy et al., 1999).”
ResultYamamoto, K., Ohishi, M., Katsuya, T., Ito, N., Ikushima, M., Kaibe, M., Tatara, Y., Shiota, A., Sugano, S., Takeda, S., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000205833.89478.5b · Cited by 323
Angiotensin-(1–7) Attenuates the Development of Heart Failure After Myocardial Infarction in Rats
Loot, A. E., Roks, A. J. M., Henning, R. H., Tio, R. A., Suurmeijer, A. J. H., Boomsma, F., & van Gilst, W. H. (2002) · Circulation · doi:10.1161/01.cir.0000013847.07035.b9 · Cited by 321 · cited 2×
“In particular, Ang (1-7) exerted anti-growth and anti-fibrotic effects in rat models of MI, neointimal formation and fibrosis (Strawn et al., 1999; Loot et al., 2002; Benter et al., 2006; Grobe et al., 2006 Grobe et al., , 2007 .”
BackgroundEffects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
Campbell, D. J., Kladis, A., & Duncan, A. M. (1994) · Hypertension · doi:10.1161/01.hyp.23.4.439 · Cited by 317 · cited 3×
“However, in many instances, AT1R antagonists as well as ACE inhibitors both elevate plasma Ang (1–7) (Campbell et al., 1991; Campbell et al., 1994), and a similar finding has been made for plasma Ang IV levels in hypertensive patients (Shibasaki et al., 1999).”
BackgroundExpression of the Subtype 2 Angiotensin (AT2) Receptor Protein in Rat Kidney
Ozono, R., Wang, Z.-Q., Moore, A. F., Inagami, T., Siragy, H. M., & Carey, R. M. (1997) · Hypertension · doi:10.1161/01.hyp.30.5.1238 · Cited by 317 · cited 3×
“Generally, AT2R mRNA and protein have been found to be distributed throughout tubular and vascular segments of the renal cortex and medulla, however, the demonstration of glomerular AT2R is more variable (Ozono et al., 1997; Miyata et al., 1999; Cao et al., 2000; Ruiz-Ortega et al., 2003).”
BackgroundSiragy, H. M., & Carey, R. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118630 · Cited by 314 · cited 7×
“Seminal studies by Siragy and Carey (1996 , 1997 Jin et al., 2004) demonstrated that increased renal interstitial levels of cGMP, NO and BK were dependent on AT 2 R activation, and led to natriuresis.”
BackgroundInfluentialCardiac renin and angiotensins. Uptake from plasma versus in situ synthesis.
Danser, A. H., van Kats, J. P., Admiraal, P. J., Derkx, F. H., Lamers, J. M., Verdouw, P. D., Saxena, P. R., & Schalekamp, M. A. (1994) · Hypertension · doi:10.1161/01.hyp.24.1.37 · Cited by 311 · cited 2×
“Indeed it was demonstrated that amajor source of renin/prorenin in cardiac tissue is due to sequestration and uptake from the circulation (Danser et al., 1994; Muller et al., 1998) suggesting a functional role for prorenin.”
BackgroundZisman, L. S., Keller, R. S., Weaver, B., Lin, Q., Speth, R., Bristow, M. R., & Canver, C. C. (2003) · Circulation · doi:10.1161/01.cir.0000094734.67990.99 · Cited by 308 · cited 2×
“Indeed, the ability of failing human hearts to produce Ang (1–7) via ACE2 was directly correlated with AT2R, but not AT1R, density (Zisman et al., 2003), further supporting the concept of endogenous AT2R ligands modulating the effects of Ang II.”
BackgroundSchefe, J. H., Menk, M., Reinemund, J., Effertz, K., Hobbs, R. M., Pandolfi, P. P., Ruiz, P., Unger, T., & Funke-Kaiser, H. (2006) · Circulation Research · doi:10.1161/01.res.0000251700.00994.0d · Cited by 302 · cited 10×
“…direct interaction between (P)RR and the transcription factor, promyelocytic zinc finger protein (PLZF), has recently identified a novel signal transduction cascade involving renin/(P)RR/PLZF, activation of which results in cellular proliferation via upregulation of PI3K-p85α (Schefe et al., 2006).”
BackgroundInfluentialIchihara, S., Senbonmatsu, T., Price, E., Ichiki, T., Gaffney, F. A., & Inagami, T. (2001) · Circulation · doi:10.1161/01.cir.104.3.346 · Cited by 299 · cited 3×
“Similarly, in AT2R knockout mice, the cardiac hypertrophic response to aortic banding, Ang II infusion or MI was absent in AT2R-deficient animals (Senbonmatsu et al., 2000; Ichihara et al., 2001; Ichihara et al., 2002), indicating a requisite presence of AT2R for cardiomyocyte hypertrophy.”
BackgroundInfluentialHoriuchi, M., Hayashida, W., Kambe, T., Yamada, T., & Dzau, V. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.19022 · Cited by 295 · cited 3×
“Thus Ang II stimulation of AT2R may result in activation of PTPases via both G-proteindependent and -independent mechanisms.”
BackgroundDaugherty, A., Manning, M. W., & Cassis, L. A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704331 · Cited by 289 · cited 4×
“Consistent with the anti-atherosclerotic role of AT2R deduced from knockout studies, Daugherty et al. (2001) had previously demonstrated that Ang II-induced atherosclerosis and aneurysm formation in male ApoE-KOmice was significantly potentiated with AT2R blockade.”
BackgroundResultInfluentialOpposing Actions of Angiotensin II on Microvascular Growth and Arterial Blood Pressure
Munzenmaier, D. H., & Greene, A. S. (1996) · Hypertension · doi:10.1161/01.hyp.27.3.760 · Cited by 288 · cited 2×
“Initially, in vivo studies deduced a vasodilator function of the AT2R since Ang II evoked either an augmented vasodepressor effect in the presence of AT1R blockade or an enhanced vasoconstriction during AT2R blockade (Scheuer & Perrone, 1993; Munzenmaier & Greene, 1996).”
BackgroundTherapeutic implications of the gender-specific aspects of cardiovascular disease
Regitz-Zagrosek, V. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2032 · Cited by 284 · cited 1×
“Gender-specific modulation of cardiovascular disease, and the treatment thereof, represents an important area for future research (Regitz-Zagrosek, 2006) .”
BackgroundFeldman, D. L., Jin, L., Xuan, H., Contrepas, A., Zhou, Y., Webb, R. L., Mueller, D. N., Feldt, S., Cumin, F., Maniara, W., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.108845 · Cited by 283 · cited 2×
“nephropathy (Feldman et al., 2008), cardiac remodelling and fibrosis (Pilz et al.”
BackgroundSuzuki, J., Matsubara, H., Urakami, M., & Inada, M. (1993) · Circulation Research · doi:10.1161/01.res.73.3.439 · Cited by 283 · cited 2×
“In animal models, AT2R expression is also increased by cardiac hypertrophy and heart failure, either in terms of absolute numbers, or relative to AT1R expression (Suzuki et al., 1993; Lopez et al., 1994; Nio et al., 1995; Ohkubo et al., 1997; Bartunek et al., 1999; Busche et al., 2000).”
BackgroundDistribution of angiotensin AT1and AT2receptor subtypes in the rat kidney
Miyata, N., Park, F., Li, X. F., & Cowley, A. W. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.277.3.f437 · Cited by 270 · cited 2×
“Generally, AT2R mRNA and protein have been found to be distributed throughout tubular and vascular segments of the renal cortex and medulla, however, the demonstration of glomerular AT2R is more variable (Ozono et al., 1997; Miyata et al., 1999; Cao et al., 2000; Ruiz-Ortega et al., 2003).”
BackgroundDiscovery of a distinct binding site for angiotensin II (3–8), a putative angiotensin IV receptor
Swanson, G. N., Hanesworth, J. M., Sardinia, M. F., Coleman, J. K. M., Wright, J. W., Hall, K. L., Miller-Wing, A. V., Stobb, J. W., Cook, V. I., Harding, E. C., et al. (1992) · Regulatory Peptides · doi:10.1016/0167-0115(92)90527-2 · Cited by 268 · cited 11×
“This hexapeptide has a much lower binding affinity than Ang II for AT2R (Bouley et al., 1998; Hansen et al., 2000), unlike AT4R; nevertheless there are functional data indicating that Ang IV exerts vascular effects via AT2R (Loufrani et al., 1999; Faure et al., 2006).”
BackgroundInfluentialAngiotensin AT2 receptor protects against cerebral ischemia‐induced neuronal injury
Li, J., Culman, J., Hörtnagl, H., Zhao, Y., Gerova, N., Timm, M., Blume, A., Zimmermann, M., Seidel, K., Dirnagl, U., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2960fje · Cited by 266 · cited 4×
“…laboratories, it was found that central administration of PD 123319 abolished the neuroprotective effects of central AT1 receptor blockade in conscious rats, both in terms of infarct size and neurological outcome following a transient unilateral medial cerebral artery occlusion (Li et al., 2005b).”
BackgroundInfluentialIchihara, A., Kaneshiro, Y., Takemitsu, T., Sakoda, M., Suzuki, F., Nakagawa, T., Nishiyama, A., Inagami, T., & Hayashi, M. (2006) · Hypertension · doi:10.1161/01.hyp.0000215838.48170.0b · Cited by 264 · cited 2×
“This group reported that HRP treatment prevented the development of diabetic nephropathy in streptozotocin (STZ)-induced diabetic rats (Ichihara et al., 2004) , and also decreased perivascular fibrosis and left ventricular hypertrophy (LVH) in spontaneously hypertensive stroke prone rats (Ichihara et al., 2006) .”
BackgroundNishimura, Y., Ito, T., & Saavedra, J. M. (2000) · Stroke · doi:10.1161/01.str.31.10.2478 · Cited by 262 · cited 2×
“Underlying mechanisms may involve the inhibition of AT1R-mediated cerebrovascular pathological growth and inflammation, as well as improved cerebrovascular compliance and autoregulation (Nishimura et al., 2000; Saavedra et al., 2006).”
BackgroundAngiotensin Receptors and Their Therapeutic Implications
Greindling, K. K., Lassegue, B., & Alexander, R. W. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.001433 · Cited by 262 · cited 2×
“Both AT1 and AT2R possess similar affinity for Ang II (Timmermans et al., 1991; Griendling et al., 1996), however, affinity for entities such as the biphenyl tetrazoles, losartan and candesartan, and compounds such as PD123319 and CGP42112, vary significantly.”
BackgroundMasaki, H., Kurihara, T., Yamaki, A., Inomata, N., Nozawa, Y., Mori, Y., Murasawa, S., Kizima, K., Maruyama, K., Horiuchi, M., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1885 · Cited by 260 · cited 1×
“In mice with targeted over-expression of vascular (Tsutsumi et al., 1999) or cardiac (Masaki et al., 1998) AT2R, there was no change in basal BP, although acute Ang II infusion decreased BP. Stimulation of AT2R by chronic Ang II infusion during AT1R blockade failed to decrease BP (Cao et al., 1999;…”
BackgroundDaugherty, A., Rateri, D. L., Lu, H., Inagami, T., & Cassis, L. A. (2004) · Circulation · doi:10.1161/01.cir.0000150540.54220.c4 · Cited by 258 · cited 4×
“The authors reported that these mice do not exhibit an increase in atherosclerosis (Daugherty et al., 2004), however, no data was presented to support such a statement.”
BackgroundInfluentialThe AT2 receptor—A matter of love and hate
Steckelings, U. M., Kaschina, E., & Unger, T. (2005) · Peptides · doi:10.1016/j.peptides.2005.03.010 · Cited by 257 · cited 1×
“The topic of AT2R signalling has recently been extensively reviewed (Hannan & Widdop, 2004; Kaschina & Unger, 2003; Steckelings et al., 2005), and so will only be mentioned briefly.”
BackgroundCoronary Kinin Generation Mediates Nitric Oxide Release After Angiotensin Receptor Stimulation
Seyedi, N., Xu, X., Nasjletti, A., & Hintze, T. H. (1995) · Hypertension · doi:10.1161/01.hyp.26.1.164 · Cited by 254 · cited 2×
“, 2003), and N1E-115 neuroblastoma cells, and in isolated blood vessels from animal (Boulanger et al., 1995; Seyedi et al., 1995; Thorup et al., 1998; Thorup et al., 1999; Hannan et al., 2003), and human (Batenburg et al.”
BackgroundBottari, S. P., King, I. N., Reichlin, S., Dahlstroem, I., Lydon, N., & de Gasparo, M. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91629-5 · Cited by 252 · cited 2×
“Increased PTPase activity following AT 2 R stimulation has been demonstrated in PC12W cells (Bottari et al., 1992; Brechler et al., 1994) , N1E-115 neuroblastoma cells (Nahmias et al., 1995) and R3T3 fibroblasts (Tsuzuki et al., 1996) .”
BackgroundPossible Inhibition of Focal Cerebral Ischemia by Angiotensin II Type 2 Receptor Stimulation
Iwai, M., Liu, H.-W., Chen, R., Ide, A., Okamoto, S., Hata, R., Sakanaka, M., Shiuchi, T., & Horiuchi, M. (2004) · Circulation · doi:10.1161/01.cir.0000138848.58269.80 · Cited by 252 · cited 3×
“Moreover, AT 2 R-deficient mice display a larger ischemic area and a more severe neurological deficit following stroke when compared to wild type (Iwai et al., 2004) , implicating a neuroprotective role for the AT 2 R. In this context, the neuroprotective effect of valsartan was reduced in AT 2 R knockout animals (Iwa…”
BackgroundChapman, N., Huxley, R., Anderson, C., Bousser, M. G., Chalmers, J., Colman, S., Davis, S., Donnan, G., MacMahon, S., Neal, B., et al. (2004) · Stroke · doi:10.1161/01.str.0000106480.76217.6f · Cited by 252 · cited 2×
“On the basis of several large-scale clinical trials, it is now accepted that chronic inhibition of the RAS can provide neuroprotection, with reduced occurrence of stroke in high-risk populations (Dahlof et al., 2002; Arnold et al., 2003; Chapman et al., 2004; Schrader et al., 2005).”
BackgroundStrauss, M. H., & Hall, A. S. (2006) · Circulation · doi:10.1161/circulationaha.105.594986 · Cited by 249 · cited 5×
“As explanation for potential differences between sartans and ACE inhibitors, it was argued that the ability of AT 1 R antagonists to indirectly facilitate AT 2 R stimulation may contribute to the risk of MI in high-risk patients (Strauss & Hall, 2006) .”
BackgroundResultInfluentialProtective Role of the Angiotensin AT 2 Receptor in a Renal Wrap Hypertension Model
Siragy, H. M., & Carey, R. M. (1999) · Hypertension · doi:10.1161/01.hyp.33.5.1237 · Cited by 246 · cited 5×
“Moreover, PD123319 reversed the natriuretic and diuretic effects of candesartan, suggesting an involvement of AT2R in the effect of the latter compound (Hakam & Hussain, 2005), consistent with earlier studies (Siragy & Carey, 1999; Siragy et al., 1999).”
BackgroundResultInfluentialOhkubo, N., Matsubara, H., Nozawa, Y., Mori, Y., Murasawa, S., Kijima, K., Maruyama, K., Masaki, H., Tsutumi, Y., Shibazaki, Y., et al. (1997) · Circulation · doi:10.1161/01.cir.96.11.3954 · Cited by 246 · cited 3×
“In animal models, AT2R expression is also increased by cardiac hypertrophy and heart failure, either in terms of absolute numbers, or relative to AT1R expression (Suzuki et al., 1993; Lopez et al., 1994; Nio et al., 1995; Ohkubo et al., 1997; Bartunek et al., 1999; Busche et al., 2000).”
BackgroundAliskiren, a Human Renin Inhibitor, Ameliorates Cardiac and Renal Damage in Double-Transgenic Rats
Pilz, B., Shagdarsuren, E., Wellner, M., Fiebeler, A., Dechend, R., Gratze, P., Meiners, S., Feldman, D. L., Webb, R. L., Garrelds, I. M., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000179573.91016.3f · Cited by 245 · cited 1×
“More recently, aliskiren has proven to be beneficial in several pathophysiological settings including hypertension and diabetic nephropathy (Feldman et al., 2008), cardiac remodelling and fibrosis (Pilz et al., 2005; Whaley-Connell et al., 2008) as well as atherosclerosis (Lu et al., 2008).”
BackgroundKeidar, S., Kaplan, M., Pavlotzky, E., Coleman, R., Hayek, T., Hamoud, S., & Aviram, M. (2004) · Circulation · doi:10.1161/01.cir.0000127949.05756.9d · Cited by 244 · cited 2×
“Furthermore, other factors involved in cellular growth and ECM production which are known to be stimulated by Ang II, such as growth factors (Parker et al., 1998; Su et al., 2002) , factors involved in the inflammatory response (Chou et al., 1998) and reactive oxygen species (ROS) (Virdis et al., 2002; Keidar et al.,…”
BackgroundRenin, Prorenin and the Putative (Pro)renin Receptor
Danser, A. H. J., & Deinum, J. (2005) · Hypertension · doi:10.1161/01.hyp.0000186329.92187.2e · Cited by 243
Differential regulation of angiotensin peptide levels in plasma and kidney of the rat.
Campbell, D. J., Lawrence, A. C., Towrie, A., Kladis, A., & Valentijn, A. J. (1991) · Hypertension · doi:10.1161/01.hyp.18.6.763 · Cited by 242 · cited 3×
“However, in many instances, AT1R antagonists as well as ACE inhibitors both elevate plasma Ang (1–7) (Campbell et al., 1991; Campbell et al., 1994), and a similar finding has been made for plasma Ang IV levels in hypertensive patients (Shibasaki et al., 1999).”
BackgroundTsutsumi, Y., Matsubara, H., Ohkubo, N., Mori, Y., Nozawa, Y., Murasawa, S., Kijima, K., Maruyama, K., Masaki, H., Moriguchi, Y., et al. (1998) · Circulation Research · doi:10.1161/01.res.83.10.1035 · Cited by 241 · cited 2×
“…AT1R, is upregulated in certain conditions, such that increased AT2R expression has been reported in patients with heart failure, ischemic heart disease, and dilated cardiomyopathy (RegitzZagrosek et al., 1995; Asano et al., 1997; Haywood et al., 1997; Tsutsumi et al., 1998; Wharton et al., 1998).”
BackgroundFerrario, C. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000196268.08909.fb · Cited by 241 · cited 2×
“Updated biochemical and functional aspects of Ang (1-7) have recently been reviewed (Ferrario et al., 2005b; Ferrario, 2006; Reudelhuber, 2006; Santos & Ferreira, 2007) .”
BackgroundRecent advances in angiotensin II signaling
Touyz, R. M., & Berry, C. (2002) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2002000900001 · Cited by 239 · cited 2×
“Signaling mechanisms differ markedly to those associated with AT1R (Touyz & Berry, 2002).”
BackgroundHuentelman, M. J., Grobe, J. L., Vazquez, J., Stewart, J. M., Mecca, A. P., Katovich, M. J., Ferrario, C. M., & Raizada, M. K. (2005) · Experimental Physiology · doi:10.1113/expphysiol.2005.031096 · Cited by 237 · cited 2×
“Similarly, in normotensive rats, ACE2 over-expression induced by lentiviral administration of ACE2 mRNA, did not affect basal cardiac function, however, transgenic animals displayed significantly blunted cardiac hypertrophic and fibrotic responses to Ang II infusion compared to control animals (Huentelman et al., 2005…”
BackgroundImpairment of In Vitro and In Vivo Heart Function in Angiotensin-(1-7) Receptor Mas Knockout Mice
Santos, R. A. S., Castro, C. H., Gava, E., Pinheiro, S. V. B., Almeida, A. P., de Paula, R. D., Cruz, J. S., Ramos, A. S., Rosa, K. T., Irigoyen, M. C., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000215289.51180.5c · Cited by 237 · cited 2×
“In addition, extracellular matrix (ECM) remodeling in the heart leading to collagen accumulation and impaired heart functionwas seen inMasR-deficientmice (Santos et al., 2006).”
BackgroundWhat?s new in the renin-angiotensin system?: The angiotensin IV/AT4 receptor
Chai, S. Y., Fernando, R., Peck, G., Ye, S. Y., Mendelsohn, F. A. O., Jenkins, T. A., & Albiston, A. L. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4246-1 · Cited by 237
Redox‐dependent signalling by angiotensin II and vascular remodelling in hypertension
Touyz, R. M., Tabet, F., & Schiffrin, E. L. (2003) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2003.03930.x · Cited by 236 · cited 2×
“Furthermore, other factors involved in cellular growth and ECM production which are known to be stimulated by Ang II, such as growth factors (Parker et al., 1998; Su et al., 2002) , factors involved in the inflammatory response (Chou et al., 1998) and reactive oxygen species (ROS) (Virdis et al., 2002; Keidar et al.,…”
BackgroundHein, L. (1997) · Molecular Endocrinology · doi:10.1210/me.11.9.1266 · Cited by 236
Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study
Arnold, J. M. O., Yusuf, S., Young, J., Mathew, J., Johnstone, D., Avezum, A., Lonn, E., Pogue, J., & Bosch, J. (2003) · Circulation · doi:10.1161/01.cir.0000054165.93055.42 · Cited by 236 · cited 4×
“On the basis of several large-scale clinical trials, it is now accepted that chronic inhibition of the RAS can provide neuroprotection, with reduced occurrence of stroke in high-risk populations (Dahlof et al., 2002; Arnold et al., 2003; Chapman et al., 2004; Schrader et al., 2005) .”
BackgroundInfluentialFeldt, S., Batenburg, W. W., Mazak, I., Maschke, U., Wellner, M., Kvakan, H., Dechend, R., Fiebeler, A., Burckle, C., Contrepas, A., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.101444 · Cited by 236 · cited 11×
“…the beneficial effects of HRP in vivo, and thus saw no improvement in end-organ damage following HRP administration in double-transgenic rats overexpressing renin and angiotensinogen genes (Feldt et al., 2008b), or in renovascular hypertensive 2-kidney, 1-clip (2K1C) rats (Muller et al., 2008).”
BackgroundInfluentialAging Increases Aortic MMP-2 Activity and Angiotensin II in Nonhuman Primates
Wang, M., Takagi, G., Asai, K., Resuello, R. G., Natividad, F. F., Vatner, D. E., Vatner, S. F., & Lakatta, E. G. (2003) · Hypertension · doi:10.1161/01.hyp.0000073843.56046.45 · Cited by 234 · cited 3×
“Circulating levels of Ang II are reduced by aging whereas angiotensinogen, ACE, and AT 1 R are upregulated in both the heart and vasculature (Heymes et al., 1994 (Heymes et al., , 1998 Wang et al., 2003) .”
BackgroundThe ‘magic tail’ of G protein‐coupled receptors: an anchorage for functional protein networks
Bockaert, J., Marin, P., Dumuis, A., & Fagni, L. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00453-8 · Cited by 234 · cited 1×
“GPCRs are now thought to interact with a range of other accessory proteins (see Bockaert et al., 2003).”
BackgroundJan Danser, A. H., Derkx, F. H. M., Schalekamp, M. A. D. H., Hense, H.-W., Riegger, G. A. J., & Schunkert, H. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816060-00017 · Cited by 232 · cited 2×
“…number of tissues, it has been suggested that prorenin represents up to 90% of total plasma renin in normal subjects, and in certain physiological and pathological conditions, such as pregnancy and diabetes, can circulate at 100-fold higher concentrations than mature renin (Danser et al., 1998).”
BackgroundACE2 gene expression is up-regulated in the human failing heart
Goulter, A. B., Goddard, M. J., Allen, J. C., & Clark, K. L. (2004) · BMC Medicine · doi:10.1186/1741-7015-2-19 · Cited by 231 · cited 2×
“Early investigations regarding ACE2 suggested that ACE2 mRNA was increased in both human and animal models of heart failure (Goulter et al., 2004; Burrell et al., 2005) and decreased in genetically hypertensive rats (Crackower et al., 2002), sparking interest that ACE2 may play an important…”
BackgroundSenbonmatsu, T., Ichihara, S., Price, E., Gaffney, F. A., & Inagami, T. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10037 · Cited by 230 · cited 6×
“Although 2 separate groups have reported a stimulatory effect of AT2R on cardiac collagen accumulation (Senbonmatsu et al., 2000; Ichihara et al., 2001; Ichihara et al., 2002; Yan et al., 2003), the bulk of data fromnumerous in vivo studies clearly support an inhibitory effect of AT2R on cardiac…”
BackgroundInfluentialTamarat, R., Silvestre, J.-S., Durie, M., & Levy, B. I. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000017372.76297.eb · Cited by 227 · cited 2×
“In addition, in the diabetic kidney, there is significant upregulation of various angiogenic cytokines, such as VEGF, that is mediated via AT 1 R and may thus contribute to the progression of renal injury (Pupilli et al., 1999; Tamarat et al., 2002; Rizkalla et al., 2005) .”
BackgroundBEDECS, K., ELBAZ, N., SUTREN, M., MASSON, M., SUSINI, C., STROSBERG, A. D., & NAHMIAS, C. (1997) · Biochemical Journal · doi:10.1042/bj3250449 · Cited by 226 · cited 1×
“However, studies performed in N1E-115 cells demonstrated that AT2R-mediated activation of PTPase did not involve a G-protein, but rather induced the soluble PTPase, SHP-1 (Bedecs et al., 1997).”
BackgroundAngiotensin AT2 receptors: cardiovascular hope or hype?
Widdop, R. E., Jones, E. S., Hannan, R. E., & Gaspari, T. A. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705448 · Cited by 223 · cited 4×
“Nevertheless, the cardiac hypertrophic effects of AT2R are controversial, with either no effect or hypertrophy being attributed to cardiac AT2R in different AT2R knockout strains subjected to various cardiac loads (Akishita et al., 2000b; Senbonmatsu et al., 2000; Widdop et al., 2003).”
BackgroundResultInfluentialSelf-citationChronic angiotensin-(1–7) prevents cardiac fibrosis in DOCA-salt model of hypertension
Grobe, J. L., Mecca, A. P., Mao, H., & Katovich, M. J. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01170.2005 · Cited by 222 · cited 3×
“Likewise, the effects of chronic Ang (1–7) or Ang IV infusions are strikingly different to those of Ang II itself (Grobe et al., 2006, 2007; Vinh et al., 2008a,b).”
BackgroundElevated Blood Pressure and Heart Rate in Human Renin Receptor Transgenic Rats
Burcklé, C. A., Jan Danser, A. H., Müller, D. N., Garrelds, I. M., Gasc, J.-M., Popova, E., Plehm, R., Peters, J., Bader, M., & Nguyen, G. (2006) · Hypertension · doi:10.1161/01.hyp.0000199912.47657.04 · Cited by 221 · cited 2×
“with increased aged (Burckle et al., 2006), lending weight to the”
BackgroundWu, L., Iwai, M., Nakagami, H., Li, Z., Chen, R., Suzuki, J., Akishita, M., de Gasparo, M., & Horiuchi, M. (2001) · Circulation · doi:10.1161/hc4601.099404 · Cited by 217 · cited 4×
“Furthermore, the protective effects of AT1R blockade using valsartan were decreased in AT2R knockout mice, suggesting involvement of AT2R stimulation in the protection associated with AT1R blockade (Wu et al., 2001).”
BackgroundMethodInfluentialShibouta, Y., Inada, Y., Ojima, M., Wada, T., Noda, M., Sanada, T., Kubo, K., Kohara, Y., Naka, T., & Nishikawa, K. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38306-0 · Cited by 213 · cited 2×
“candesartan, has 80 times higher affinity for the AT1R than losartan (Shibouta et al., 1993; Morsing, 1999).”
BackgroundAngiotensin II stimulates the production of NO and peroxynitrite in endothelial cells
Pueyo, M. E., Arnal, J.-F., Rami, J., & Michel, J.-B. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.1.c214 · Cited by 212 · cited 2×
“In cultured endothelial (Chaki & Inagami, 1993; Caputo et al., 1995; Saito et al., 1996; Pueyo et al., 1998), PC12W (Zhao et al., 2003), and N1E-115 neuroblastoma cells, and in isolated blood vessels from animal (Boulanger et al., 1995; Seyedi et al., 1995; Thorup et al., 1998; Thorup et al., 1999;…”
BackgroundAngiotensin receptor blockers and myocardial infarction
Verma, S., & Strauss, M. (2004) · BMJ · doi:10.1136/bmj.329.7477.1248 · Cited by 210 · cited 1×
“Based on the results of this trial, Verma & Strauss (2004) initiated a debate that is still ongoing, as to the potential harm of sartans for MI in high-risk patients (Verma & Strauss, 2004 ) (for detailed review, see Strauss & Hall, 2006; Tsuyuki & McDonald, 2006) .”
ResultThe Angiotensin IV System: Functional Implications
Wright, J. W., Krebs, L. T., Stobb, J. W., & Harding, J. W. (1995) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1995.1002 · Cited by 210 · cited 11×
“This hexapeptide has a much lower binding affinity than Ang II for AT2R (Bouley et al., 1998; Hansen et al., 2000), unlike AT4R; nevertheless there are functional data indicating that Ang IV exerts vascular effects via AT2R (Loufrani et al., 1999; Faure et al., 2006).”
BackgroundInfluentialRenin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice
Lu, H., Rateri, D. L., Feldman, D. L., Jr., R. J. C., Fukamizu, A., Ishida, J., Oesterling, E. G., Cassis, L. A., & Daugherty, A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32970 · Cited by 208 · cited 2×
“More recently, aliskiren has proven to be beneficial in several pathophysiological settings including hypertension and diabetic nephropathy (Feldman et al., 2008), cardiac remodelling and fibrosis (Pilz et al., 2005; Whaley-Connell et al., 2008) as well as atherosclerosis (Lu et al., 2008).”
BackgroundAngiotensin-(1-7)–Stimulated Nitric Oxide and Superoxide Release From Endothelial Cells
Heitsch, H., Brovkovych, S., Malinski, T., & Wiemer, G. (2001) · Hypertension · doi:10.1161/01.hyp.37.1.72 · Cited by 208 · cited 2×
“Moreover there are other functional andmolecular data to support this claim that Ang (1–7) can stimulate AT2R (Jaiswal et al., 1993; Muthalif et al., 1998; Hansen et al., 2000; Heitsch et al., 2001; De Souza et al., 2004; Castro et al., 2005; Lara Lda et al., 2006) often despite low potency (Hansen et al.”
BackgroundLucius, R., Gallinat, S., Rosenstiel, P., Herdegen, T., Sievers, J., & Unger, T. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.4.661 · Cited by 206 · cited 6×
“At first glance, it seems contradictory that AT2R would be involved in both apoptosis and neuronal regeneration, however, during early stages, neuronal injury will initiate a series of events that are identical for apoptosis and regeneration (Lucius et al., 1998).”
BackgroundResultInfluentialWalters, P. E., Gaspari, T. A., & Widdop, R. E. (2005) · Hypertension · doi:10.1161/01.hyp.0000160325.59323.b8 · Cited by 206 · cited 10×
“…pathways has also been demonstrated following AT2R stimulation in vivo, in the vasculature of rats (Siragy & Carey, 1996, 1997, 1999; Siragy et al., 2000, 2001; Walters et al., 2005), and mice (Tsutsumi et al., 1999), and in cardiac growth responses (Liu et al., 1997; Bartunek et al., 1999).”
BackgroundResultInfluentialSelf-citationAliskiren: the first renin inhibitor for clinical treatment
Jensen, C., Herold, P., & Brunner, H. R. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2550 · Cited by 205 · cited 2×
“Animal and clinical studies have revealed striking depressor effects of aliskiren (Jensen et al., 2008).”
BackgroundIto, T., Yamakawa, H., Bregonzio, C., Terrón, J. A., Falcón-Neri, A., & Saavedra, J. M. (2002) · Stroke · doi:10.1161/01.str.0000027274.03779.f3 · Cited by 205 · cited 2×
“In accordance with human clinical trials, animal studies have also concluded that inhibition of the RAS protects against neuronal injury following stroke, often in a BP-independent manner (Ito et al., 2002; Groth et al., 2003) .”
ResultLopez, J. J., Lorell, B. H., Ingelfinger, J. R., Weinberg, E. O., Schunkert, H., Diamant, D., & Tang, S. S. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.267.2.h844 · Cited by 202 · cited 3×
“In animal models, AT2R expression is also increased by cardiac hypertrophy and heart failure, either in terms of absolute numbers, or relative to AT1R expression (Suzuki et al., 1993; Lopez et al., 1994; Nio et al., 1995; Ohkubo et al., 1997; Bartunek et al., 1999; Busche et al., 2000).”
BackgroundACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR
Díez-Freire, C., Vázquez, J., Correa de Adjounian, M. F., Ferrari, M. F. R., Yuan, L., Silver, X., Torres, R., & Raizada, M. K. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00312.2005 · Cited by 200 · cited 2×
“…performed by the same group, ACE2 over-expression in SHR and WKY rats, reduced blood pressure (BP), decreased left ventricular wall thickness, increased left ventricular end diastolic pressure, and attenuated cardiac perivascular fibrosis in hypertensive animals only (Diez-Freire et al., 2006).”
BackgroundAngiotensin II Type 2 Receptor–Mediated Vasodilation in Human Coronary Microarteries
Batenburg, W. W., Garrelds, I. M., Bernasconi, C. C., Juillerat-Jeanneret, L., van Kats, J. P., Saxena, P. R., & Danser, A. H. J. (2004) · Circulation · doi:10.1161/01.cir.0000128696.12245.57 · Cited by 199 · cited 2×
“…cells, and in isolated blood vessels from animal (Boulanger et al., 1995; Seyedi et al., 1995; Thorup et al., 1998; Thorup et al., 1999; Hannan et al., 2003), and human (Batenburg et al., 2004) studies, Ang II has been shown to increase NO and/or cGMP levels via AT2R and/ or AT1R stimulation.”
BackgroundAVE 0991, a Nonpeptide Mimic of the Effects of Angiotensin-(1–7) on the Endothelium
Wiemer, G., Dobrucki, L. W., Louka, F. R., Malinski, T., & Heitsch, H. (2002) · Hypertension · doi:10.1161/01.hyp.0000037979.53963.8f · Cited by 199 · cited 5×
“More recently, chronic AVE0991 administration was reported to attenuate heart failure induced by MI (Ferreira et al., 2007) although the ATR subtype mediating this effect was not investigated.”
BackgroundInfluentialSILVAANTONIALLI, M. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.01.020 · Cited by 198 · cited 1×
“This effect was due to reciprocal changes in AT 1 R (decreased) and AT 2 R (increased) in the kidneys whereas AT 1 R, but not AT 2 R, was downregulated in aortic and mesenteric vessels of female SHR, in an oestrogen-sensitive manner (Silva-Antonialli et al., 2004) .”
BackgroundAngiotensin II(3–8) (ANG IV) hippocampal binding: Potential role in the facilitation of memory
Wright, J. W., Miller-Wing, A. V., Shaffer, M. J., Higginson, C., Wright, D. E., Hanesworth, J. M., & Harding, J. W. (1993) · Brain Research Bulletin · doi:10.1016/0361-9230(93)90297-o · Cited by 198 · cited 4×
“or PD123319 (Wright et al., 1993), and has been designated the angiotensin II type 4 receptor (AT4R) (Swanson et al.”
BackgroundInfluentialUnger, T., Chung, O., Csikós, T., Čulman, J., GALLINAT, S., Gohlke, P., Höhle, S., Meffert, S. H., Stoll, M., Stroth, U., et al. (1996) · PubMed · Cited by 195
Keidar, S., Gamliel-Lazarovich, A., Kaplan, M., Pavlotzky, E., Hamoud, S., Hayek, T., Karry, R., & Abassi, Z. (2005) · Circulation Research · doi:10.1161/01.res.0000187500.24964.7a · Cited by 193 · cited 2×
“treatment also increased ACE2 in heart failure patients (Keidar et al., 2005).”
BackgroundA novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy
Senbonmatsu, T. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg637 · Cited by 192 · cited 11×
“Interestingly, PLZF has also been found to associate with AT2R in the heart (Senbonmatsu et al., 2003), and such an interaction has been suggested as explanation for the AT2R-mediated cardiac growth-promoting effects deduced from several AT2R knockout studies (Senbonmatsu et al., 2000; Ichihara et…”
BackgroundInfluentialRegitz-Zagrosek, V., Friedel, N., Heymann, A., Bauer, P., Neuß, M., Rolfs, A., Steffen, C., Hildebrandt, A., Hetzer, R., & Fleck, E. (1995) · Circulation · doi:10.1161/01.cir.91.5.1461 · Cited by 191
Nouet, S., Amzallag, N., Li, J.-M., Louis, S., Seitz, I., Cui, T.-X., Alleaume, A.-M., Di Benedetto, M., Boden, C., Masson, M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403880200 · Cited by 189 · cited 2×
“Binding of endogenous ATIP1 to the C-terminal tail of the AT2R inhibited mitogenic pathway signalling, an effect which was potentiated by ligand activation, but was also present in the absence of such stimuli (Nouet et al., 2004).”
BackgroundRenin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy
Mezzano, S., Droguett, A., Burgos, M. E., Ardiles, L. G., Flores, C. A., Aros, C. A., Caorsi, I., Vío, C. P., Ruiz-Ortega, M., & Egido, J. (2003) · Kidney International · doi:10.1046/j.1523-1755.64.s86.12.x · Cited by 189 · cited 1×
“…and basolateral membrane of the kidney (Hakam & Hussain, 2005) which is consistent with findings from kidney biopsies of patients with type 2 diabetes in which the AT2R levels were also found to be increased in tubular cells with a concomitant reduction of AT1R expression (Mezzano et al., 2003).”
Benter, I. F., Yousif, M. H. M., Anim, J. T., Cojocel, C., & Diz, D. I. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00632.2005 · Cited by 187 · cited 2×
“rat models of MI, neointimal formation and fibrosis (Strawn et al., 1999; Loot et al., 2002; Benter et al., 2006; Grobe et al., 2006, 2007).”
BackgroundAT1and AT2Angiotensin Receptor Gene Expression in Human Heart Failure
Haywood, G. A., Gullestad, L., Katsuya, T., Hutchinson, H. G., Pratt, R. E., Horiuchi, M., & Fowler, M. B. (1997) · Circulation · doi:10.1161/01.cir.95.5.1201 · Cited by 186 · cited 1×
“…AT1R, is upregulated in certain conditions, such that increased AT2R expression has been reported in patients with heart failure, ischemic heart disease, and dilated cardiomyopathy (RegitzZagrosek et al., 1995; Asano et al., 1997; Haywood et al., 1997; Tsutsumi et al., 1998; Wharton et al., 1998).”
BackgroundAngiotensin II Induction of Neurite Outgrowth by AT2 Receptors in NG108-15 Cells
Laflamme, L., de Gasparo, M., Gallo, J.-M., Payet, M. D., & Gallo-Payet, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22729 · Cited by 186 · cited 1×
“Earlier studies (Laflamme et al., 1996) demonstrated that in vitro stimulation of AT2R was associated with intense neurite outgrowth; an effect that was negated by PD123319.”
BackgroundAngiotensin-(1–7) Reduces Smooth Muscle Growth After Vascular Injury
Strawn, W. B., Ferrario, C. M., & Tallant, E. A. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.207 · Cited by 184 · cited 2×
“rat models of MI, neointimal formation and fibrosis (Strawn et al., 1999; Loot et al., 2002; Benter et al., 2006; Grobe et al., 2006, 2007).”
BackgroundWarner, F. J., Lew, R. A., Smith, A. I., Lambert, D. W., Hooper, N. M., & Turner, A. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508914200 · Cited by 183 · cited 2×
“In addition, ACE2 is known to undergo proteolytic shedding of its extracellular ectodomain to release a soluble form of ACE2 in plasma that maintains catalytic activity (Lambert et al., 2005; Warner et al., 2005).”
BackgroundContributions of the Brain Angiotensin IV–AT4Receptor Subtype System to Spatial Learning
Wright, J. W., Stubley, L., Pederson, E. S., Kramár, E. A., Hanesworth, J. M., & Harding, J. W. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-10-03952.1999 · Cited by 182 · cited 2×
“IRAP has been localised in tissues such as heart, lung, kidney, and brain, and ligand binding results in effects such as enhancement of cognitive function (Wright et al., 1993; Wright et al., 1999) modulation of blood flow (Swanson et al.”
BackgroundDai, W.-J., Funk, A., Herdegen, T., Unger, T., & Culman, J. (1999) · Stroke · doi:10.1161/01.str.30.11.2391 · Cited by 180 · cited 2×
“Indeed, AT 2 R is capable of inducing apoptosis in PC12W cells through the induction of ceramides and the activation of MKP-1 signalling (Dai et al., 1999) .”
BackgroundRenal proximal tubular AT2 receptor: signaling and transport.
Haithcock, D., Jiao, H., Cui, X. L., Hopfer, U., & Douglas, J. G. (1999) · PubMed · Cited by 177
Wassmann, S., Czech, T., van Eickels, M., Fleming, I., Böhm, M., & Nickenig, G. (2004) · Circulation · doi:10.1161/01.cir.0000137970.47771.af · Cited by 177 · cited 2×
“…atherosclerosis, i.e. apolipoprotein E (ApoE)-deficient mice or LDL-receptor-deficient mice, both types of double knockouts exhibited markedly reduced atherosclerotic lesions (Wassmann et al., 2004; Daugherty et al., 2004), suggesting a primary role for AT1R in the pathogenesis of atherosclerosis.”
BackgroundMethodNonpeptide AVE 0991 Is an Angiotensin-(1–7) Receptor Mas Agonist in the Mouse Kidney
Pinheiro, S. V. B., Simões e Silva, A. C., Sampaio, W. O., de Paula, R. D., Mendes, E. P., Bontempo, E. D., Pesquero, J. B., Walther, T., Alenina, N., Bader, M., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000141438.64887.42 · Cited by 175 · cited 5×
“actions of Ang (1–7) being abolished in MasR-deficient mice (Santos et al., 2003; Pinheiro et al., 2004).”
BackgroundInfluentialMuthalif, M. M., Benter, I. F., Uddin, M. R., Harper, J. L., & Malik, K. U. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37208-8 · Cited by 175 · cited 2×
“Moreover there are other functional andmolecular data to support this claim that Ang (1–7) can stimulate AT2R (Jaiswal et al., 1993; Muthalif et al., 1998; Hansen et al., 2000; Heitsch et al., 2001; De Souza et al., 2004; Castro et al., 2005; Lara Lda et al., 2006) often despite low potency (Hansen et al.”
BackgroundCardiac Angiotensin II Type 2 Receptor Activates the Kinin/NO System and Inhibits Fibrosis
Kurisu, S., Ozono, R., Oshima, T., Kambe, M., Ishida, T., Sugino, H., Matsuura, H., Chayama, K., Teranishi, Y., Iba, O., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000050101.90932.14 · Cited by 173 · cited 4×
“Ang II infusion also resulted in a comparable increase in cardiac hypertrophy in mice with cardiac specific over-expression of AT 2 R, to that of wild type mice (Sugino et al., 2001; Kurisu et al., 2003) .”
BackgroundInfluentialKang, J., Posner, P., & Sumners, C. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.267.5.c1389 · Cited by 173 · cited 2×
“and -2, appears to be particularly important in neuronal tissue, in which activation of the serine/threonine phosphatase PP2A has been demonstrated to cause opening of a delayed rectifier K channel (Kang et al., 1994), upregulation of AT2R mRNA, and increased apoptosis (Shenoy et al.”
BackgroundBarber, M., Sampey, D. B., & Widdop, R. E. (1999) · Hypertension · doi:10.1161/01.hyp.34.5.1112 · Cited by 172 · cited 2×
“Using this approach, selective stimulation of AT2R by CGP42112 lowered BP, provided that there was a background of AT1R blockade in conscious rats (Barber et al., 1999; Carey et al., 2001).”
BackgroundResultSelf-citationDaviet, L., Lehtonen, J. Y. A., Tamura, K., Griese, D. P., Horiuchi, M., & Dzau, V. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17058 · Cited by 169 · cited 3×
“Conversely, ATRAP has been found to be co-localised with AT1R in renal tubules (Tsurumi et al., 2006), and in vitro studies have demonstrated that over-expression of this protein decreases AT1R-mediated signaling and cellular proliferation, thus suggesting that ATRAP may act as a negative regulator of AT1R signaling (…”
BackgroundMa, J., Nishimura, H., Fogo, A., Kon, V., Inagami, T., & Ichikawa, I. (1998) · Kidney International · doi:10.1111/j.1523-1755.1998.00893.x · Cited by 168 · cited 1×
“Thus, on balance, AT2R appear to be renoprotective, in keeping with other studies in which mice treated with PD123319, or inmicewith AT2R deleted, exhibitmarked increases in renal fibrosis (Ma et al., 1998; Morrissey & Klahr, 1999).”
ResultAsano, K., Dutcher, D. L., Port, J. D., Minobe, W. A., Tremmel, K. D., Roden, R. L., Bohlmeyer, T. J., Bush, E. W., Jenkin, M. J., Abraham, W. T., et al. (1997) · Circulation · doi:10.1161/01.cir.95.5.1193 · Cited by 168 · cited 1×
“…AT1R, is upregulated in certain conditions, such that increased AT2R expression has been reported in patients with heart failure, ischemic heart disease, and dilated cardiomyopathy (RegitzZagrosek et al., 1995; Asano et al., 1997; Haywood et al., 1997; Tsutsumi et al., 1998; Wharton et al., 1998).”
Backgroundde Castro, C. H., Souza dos Santos, R. A., Ferreira, A. J., Bader, M., Alenina, N., & Pinto de Almeida, A. (2005) · Hypertension · doi:10.1161/01.hyp.0000175813.04375.8a · Cited by 168
Angiotensin-(1–7) and the renin–angiotensin system
Santos, R. A., & Ferreira, A. J. (2007) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0b013e328031f362 · Cited by 167 · cited 4×
“Updated biochemical and functional aspects of Ang (1-7) have recently been reviewed (Ferrario et al., 2005b; Ferrario, 2006; Reudelhuber, 2006; Santos & Ferreira, 2007) .”
BackgroundInfluentialExpression of angiotensin II AT2 receptors in the rat skin during experimental wound healing
Viswanathan, M., & Saavedra, J. M. (1992) · Peptides · doi:10.1016/0196-9781(92)90187-8 · Cited by 164 · cited 1×
“…kidney, adrenal gland, brain, uterus, pancreas, retina, skin, and both endothelial and vascular smooth muscle cells (VSMCs) of the vasculature (Viswanathan & Saavedra, 1992; Leung et al., 1997; Nora et al., 1998; Allen et al., 1999;Wang et al., 1999; Wheeler-Schilling et al., 1999; Roulston…”
BackgroundLew, R. A., Mustafa, T., Ye, S., McDowall, S. G., Chai, S. Y., & Albiston, A. L. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01852.x · Cited by 163
Angiotensin II Type 2 Receptor–Bradykinin B 2 Receptor Functional Heterodimerization
Abadir, P. M., Periasamy, A., Carey, R. M., & Siragy, H. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000228997.88162.a8 · Cited by 162 · cited 5×
“This effect on AT1aR expressionwas suggested to be due to potentiated BK/NO signaling, as not only was BK and iNOS protein increased by AT2R over-expression, but both the B2R antagonist, HOE 140, and the NO synthase inhibitor, L-NAME, ameliorated the decrease in AT1aR expression (Jin et al., 2002).”
BackgroundInfluentialAngiotensin Type 2 Receptor Mediates Valsartan-Induced Hypotension in Conscious Rats
Siragy, H. M., de Gasparo, M., & Carey, R. M. (2000) · Hypertension · doi:10.1161/01.hyp.35.5.1074 · Cited by 162 · cited 4×
“In relatively short-term studies performed in rats with either renovascular hypertension or which had been sodium-depleted, the hypotensive effect of AT 1 R blockade was reversed by simultaneous administration of PD123319, suggesting a vasodilator role of the AT 2 R (Gigante et al., 1998; Siragy et al., 2000) .”
BackgroundInfluentialYang, Z., Bové, C. M., French, B. A., Epstein, F. H., Berr, S. S., DiMaria, J. M., Gibson, J. J., Carey, R. M., & Kramer, C. M. (2002) · Circulation · doi:10.1161/01.cir.0000020014.14176.6d · Cited by 162 · cited 1×
“The vast majority of investigators have deduced AT2Rmediated improvement of LV function and remodelling frommultiple studies performed in mouse models of either AT2R-deletion (Brede et al., 2003; Oishi et al., 2003) or over-expression (Yang et al., 2002; Bove et al., 2005).”
BackgroundTouyz, R. M., Endemann, D., He, G., Li, J.-S., & Schiffrin, E. L. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.366 · Cited by 161 · cited 13×
“In rat cardiac fibroblasts, collagen production was reduced by inhibition of either AT1 or AT2R (Brilla et al., 1994; Brilla et al., 1995), and chronic blockade of both AT1R and AT2R with Sar1Ile8Ang II in rats also decreased collagen deposition, suggesting a stimulatory role of AT2R in collagen synthesis (Brassard et…”
BackgroundResultInfluentialDifferential Distribution of Angiotensin AT2 Receptors in the Normal and Failing Human Heart
Wharton, J., Morgan, K., Rutherford, R. A. D., Catravas, J. D., Chester, A., Whitehead, B. F., De Leval, M. R., Yacoub, M. H., & Polak, J. M. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37201-5 · Cited by 158
Protective effect of the inhibition of the renin–angiotensin system on aging
Basso, N., Paglia, N., Stella, I., de Cavanagh, E. M. V., Ferder, L., Arnaiz, M. D. R. L., & Inserra, F. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2004.12.027 · Cited by 153 · cited 1×
“AT 1 R blockade and ACE inhibition have been shown to be effective in preventing or regressing age-associated effects on cardiovascular remodelling and function in humans and animals Basso et al., 2005) .”
MethodAT 2 Receptor-Mediated Relaxation Is Preserved After Long-Term AT 1 Receptor Blockade
Widdop, R. E., Matrougui, K., Levy, B. I., & Henrion, D. (2002) · Hypertension · doi:10.1161/01.hyp.0000033224.99806.8a · Cited by 153 · cited 3×
“, 1997; Thomas,1999), which is consistent with functional data (Widdop et al., 2002).”
BackgroundResultSelf-citationSampson, A. K., Moritz, K. M., Jones, E. S., Flower, R. L., Widdop, R. E., & Denton, K. M. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.114058 · Cited by 151
Self-citationAngiotensin III: a central regulator of vasopressin release and blood pressure
Goazigo, A. R.-L., Fournié-Zaluski, M. C., & Llorens‐Cortés, C. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00381-2 · Cited by 151 · cited 2×
“This lack of potency of Ang III is not usually the case in the central nervous system where it is proposed that Ang III is the main mediator of centrally-mediated pressor effects of Ang II, following conversion from the latter (Reaux et al., 2001; Wright et al., 2003) .”
BackgroundPupilli, C., Lasagni, L., Romagnani, P., Bellini, F., Mannelli, M., Misciglia, N., Mavilia, C., VELLEI, U., Villari, D., & Serio, M. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v102245 · Cited by 151
Viswanathan, M., Strömberg, C., Seltzer, A. M., & Saavedra, J. M. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116043 · Cited by 148 · cited 1×
“The RAS has been implicated in neointimal formation mainly via the activation of the AT1R (Kim et al., 1995; Viswanathan et al., 1992).”
BackgroundAngiotensin Type 2 Receptor-Mediated Hypotension in Angiotensin Type-1 Receptor-Blocked Rats
Carey, R. M., Howell, N. L., Jin, X.-H., & Siragy, H. M. (2001) · Hypertension · doi:10.1161/hy1201.096576 · Cited by 147 · cited 1×
“Using this approach, selective stimulation of AT2R by CGP42112 lowered BP, provided that there was a background of AT1R blockade in conscious rats (Barber et al., 1999; Carey et al., 2001).”
BackgroundPadia, S. H., Howell, N. L., Siragy, H. M., & Carey, R. M. (2005) · Hypertension · doi:10.1161/01.hyp.0000196950.48596.21 · Cited by 146 · cited 8×
“Intriguingly, Ang (1–7) and Ang III both exerted AT2R-mediated effects (Walters et al., 2003, 2005; Padia et al., 2006) under conditions inwhich Ang II itself was ineffective (Gohlke et al., 1998), which raises the distinct possibility that these smaller Ang peptide fragments are endogenous AT2R…”
BackgroundInfluentialEffects of Losartan on Angiotensin and Bradykinin Peptides and Angiotensin-Converting Enzyme
Campbell, D. J., Kladis, A., & Valentijn, A. J. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199508000-00009 · Cited by 146 · cited 2×
“Nevertheless, it is well established that there is differential regulation of Ang II and related peptides in plasma versus tissue (Campbell et al., 1991, 1994, 1995; Campbell, 1996).”
BackgroundRegulation of Transport of the Angiotensin AT2 Receptor by a Novel Membrane-Associated Golgi Protein
Wruck, C. J., Funke‐Kaiser, H., Pufe, T., Kusserow, H., Menk, M., Schefe, J. H., Kruse, M. L., Stoll, M., & Unger, T. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000150662.51436.14 · Cited by 145 · cited 3×
“…ERK1/2 activation and cellular proliferation, and interestingly, not only was this effect blocked by PD123319, but it was also significantly inhibited by ATBP50 siRNA, indicating a functional modulatory interaction between ATBP50 and AT2R-mediated anti-mitogenic signalling (Wruck et al., 2005).”
BackgroundAngiotensin-(1–7): a bioactive fragment of the renin–angiotensin system
Ferrario, C. M., & Iyer, S. N. (1998) · Regulatory Peptides · doi:10.1016/s0167-0115(98)00134-7 · Cited by 145 · cited 1×
“Ang II is susceptible todegradation by aminopeptidases, resulting in fragments such as Ang III and Ang IV, which may in themselves possess biological activity (Ferrario & Iyer, 1998; de Gasparo et al., 2000).”
Nguyen, G. (2006) · Kidney International · doi:10.1038/sj.ki.5000265 · Cited by 144 · cited 2×
“heart, brain, placenta and adipocytes, and at lower levels in kidney and liver (Danser & Deinum, 2005; Nguyen, 2006; Achard et al., 2007).”
BackgroundInhibition of pressure natriuresis in mice lacking the AT2 receptor
Groß, V., Schunck, W.-H., Honeck, H., Milia, A. F., Kärgel, E., Walther, T., Bäder, M., Inagami, T., Schneider, W., & Luft, F. C. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00820.x · Cited by 142 · cited 2×
“In AT2R knockout mice (Hein et al., 1995; Ichiki et al., 1995; Gross et al., 2000a), and rats administered AT2R antisense to ‘knockdown’ receptor expression (Wang et al., 2004), both an increase in basal BP and/ or potentiation of the pressor response to exogenous Ang II have been attributed to the…”
BackgroundInflammation influences vascular remodeling through AT2receptor expression and signaling
Akishita, M., Horiuchi, M., Yamada, H., Zhang, L., Shirakami, G., Tamura, K., Ouchi, Y., & Dzau, V. J. (2000) · Physiological Genomics · doi:10.1152/physiolgenomics.2000.2.1.13 · Cited by 142 · cited 4×
“Nevertheless, the cardiac hypertrophic effects of AT2R are controversial, with either no effect or hypertrophy being attributed to cardiac AT2R in different AT2R knockout strains subjected to various cardiac loads (Akishita et al., 2000b; Senbonmatsu et al., 2000; Widdop et al., 2003).”
BackgroundInfluentialSynthesis and effects of active fragments of angiotensin II
Ardaillou, R., & Chansel, D. (1997) · Kidney International · doi:10.1038/ki.1997.476 · Cited by 142 · cited 2×
“IRAP has been localised in tissues such as heart, lung, kidney, and brain, and ligand binding results in effects such as enhancement of cognitive function (Wright et al., 1993; Wright et al., 1999) modulation of blood flow (Swanson et al., 1992; Coleman et al., 1998) , increased natriuresis (Ardaillou & Chansel, 1997)…”
BackgroundSarlos, S., Rizkalla, B., Moravski, C. J., Cao, Z., Cooper, M. E., & Wilkinson‐Berka, J. L. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63448-7 · Cited by 141 · cited 6×
“The AT 2 R has been identified in several ocular tissues including the retina and has been found to predominate in the developing retina (Sarlos et al., 2003) consistent with the view that the AT 2 R influences cell growth and differentiation in organ development.”
BackgroundInfluentialThe Putative (Pro)renin Receptor Blocker HRP Fails to Prevent (Pro)renin Signaling
Feldt, S., Maschke, U., Dechend, R., Luft, F. C., & Müller, D. N. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091030 · Cited by 140 · cited 11×
“…the beneficial effects of HRP in vivo, and thus saw no improvement in end-organ damage following HRP administration in double-transgenic rats overexpressing renin and angiotensinogen genes (Feldt et al., 2008b), or in renovascular hypertensive 2-kidney, 1-clip (2K1C) rats (Muller et al., 2008).”
BackgroundInfluentialDifferences in Tissue Angiotensin II–Forming Pathways by Species and Organs In Vitro
Akasu, M., Urata, H., Kinoshita, A., Sasaguri, M., Ideishi, M., & Arakawa, K. (1998) · Hypertension · doi:10.1161/01.hyp.32.3.514 · Cited by 138 · cited 2×
“(Zimmerman & Dunham, 1997; Akasu et al., 1998), and it is now well accepted that in addition to systemic effects, local synthesis of Ang II exerts bothautocrine andparacrine functions, influencing cellular growth andregionalhaemodynamics ina tissue-specificmanner (Johnston,1992; Zimmerman & Dunham, 1997; de Gasparo et…”
BackgroundHenriques, T. A., Huang, J., D’Souza, S. S., Daugherty, A., & Cassis, L. A. (2004) · Endocrinology · doi:10.1210/en.2003-1615 · Cited by 135 · cited 1×
“The authors suggested gender differences may have accounted for the disparity, as it has been demonstrated that male hormones may protect against Ang II-mediated lesion development (Henriques et al., 2004).”
BackgroundLigand‐independent signals from angiotensin II type 2 receptor induce apoptosis
Miura, S.-I., & Karnik, S. S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.15.4026 · Cited by 134 · cited 4×
“Over-expression of AT 2 R in cultured fibroblasts, CHO cells and VSMCs, caused apoptosis via p38 MAPK and caspase-3 signalling pathways (Miura & Karnik, 2000) .”
BackgroundInfluentialAngiotensin Type 2 Receptor in Resistance Arteries of Type 2 Diabetic Hypertensive Patients
Savoia, C., Touyz, R. M., Volpe, M., & Schiffrin, E. L. (2007) · Hypertension · doi:10.1161/01.hyp.0000253968.95136.b8 · Cited by 134 · cited 5×
“Interestingly, AT1R blockade was shown to increase AT2R expression (2–3-fold) and NO production, and to suppress NAD(P)H-driven superoxide generation, in arteries of hypertensive SHRSP, but not normotensive WKY rats (Savoia et al., 2006a).”
BackgroundInfluentialEstrogen upregulates renal angiotensin II AT2receptors
Armando, I., Jezova, M., Juorio, A. V., Terrón, J. A., Falcón-Neri, A., Semino-Mora, C., Imboden, H., & Saavedra, J. M. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00145.2002 · Cited by 134 · cited 1×
“Discrepancies between studies may involve species differences since renal AT2R are more easily detected in mice than rats (Armando et al., 2002; Baiardi et al., 2005).”
Background
Cited by
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687
Bernardo, B. C., Weeks, K. L., Pretorius, L., & McMullen, J. R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.005 · Cited by 894
ACE2: The Major Cell Entry Receptor for SARS-CoV-2
Scialo, F., Daniele, A., Amato, F., Pastore, L., Matera, M. G., Cazzola, M., Castaldo, G., & Bianco, A. (2020) · Lung · doi:10.1007/s00408-020-00408-4 · Cited by 481
Iwai, M., & Horiuchi, M. (2009) · Hypertension Research · doi:10.1038/hr.2009.74 · Cited by 296
Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors
Bosnyak, S., Jones, E. S., Christopoulos, A., Aguilar, M.-I., Thomas, W. G., & Widdop, R. E. (2011) · Clinical Science · doi:10.1042/cs20110036 · Cited by 288
Self-citation
Metadata
- Authors
- Jones, E. S., Vinh, A., McCarthy, C. A., Gaspari, T. A., & Widdop, R. E.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 120
- Issue
- 3
- Pages
- 292-316
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W1979582673
- Cited by
- 237
- References
- 401
- FWCI
- 9.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.